GSK3B and major depressive disorder: In the present study, all three doses of GTS (50, 25, and 12.5 mg kg−1 d−1) significantly reversed the downregulated inhibitory phosphorylation of GSK-3β in this depression model, thereby suggesting that GTS may inhibit GSK-3β.